Production of a recombinant monoclonal antibody to Herpes Simplex Virus glycoprotein D for immunoaffinity purification of tagged proteins

• Published in: Journal of immunological methods Vol. 465; pp. 31 - 38
• Main Authors: O'Rourke, Sara M., Yu, Bin, Morales, Javier F., Didinger, Chelsea M., Alexander, David L., Vollmers, Christopher, Berman, Phillip W.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.02.2019
• Subjects: Animals; Antibodies; Antibodies, Monoclonal, Murine-Derived - chemistry; Antibodies, Monoclonal, Murine-Derived - genetics; Antibodies, Monoclonal, Murine-Derived - immunology; Antibodies, Viral - chemistry; Antibodies, Viral - genetics; Antibodies, Viral - immunology; CHO Cells; Cricetulus; Herpesvirus 1, Human - chemistry; Herpesvirus 1, Human - immunology; HIV-1 vaccine; Humans; Immunoaffinity chromatography; Mice; Recombinant Proteins - chemistry; Recombinant Proteins - genetics; Recombinant Proteins - immunology; Viral Envelope Proteins - chemistry; Viral Envelope Proteins - immunology; CHO-S; Immunoaffinity chromatography; Antibodies; cGMP; HIV-1 vaccine; HSV; rgD-gp120; CHO cells
• ISSN: 0022-1759; 1872-7905; 1872-7905
• DOI: 10.1016/j.jim.2018.11.015

We have developed a stable Chinese Hamster Ovary (CHO) cell line for the production of a recombinant monoclonal antibody (mAb) to a short protein sequence derived from the N-terminus of human herpes simplex virus type 1 glycoprotein D (HSV-1 gD). The antibody (designated r34.1) provides a useful tool for the immunoaffinity purification of HSV-1 gD tagged proteins, and provides a generic purification system by which various proteins and peptides can be purified. Recombinant 34.1 was assembled using cDNA derived from a HSV-1 gD specific murine hybridoma engineered to encode a full-length IgG molecule. Antibody expression cassettes were transfected into CHO-S cells, and a stable cell-line expressing up to 500 mg/L of antibody, isolated. Affinity purified r34.1 exhibited nanomolar affinity for its cognate ligand, and is stable throughout multiple cycles of immunoaffinity purification involving ligand binding at neutral pH, followed by acid elution. The HSV-1 gD tag expression and purification strategy has been used to enhance the secretion and purification of several vaccine immunogens including HIV envelope protein rgp120s, but the protocol has potential for generic application. •Robotic selection of CHO-S cell line expressing ~ 450 mg/L of antibody•HSV-1 gD tag/ immunoaffinity purification system for vaccine antigen production•New source of acid stable HSV-1 gD tag antibody